Published in J Clin Microbiol on September 06, 2006
Group A streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance. BMC Microbiol (2012) 1.08
Nonoutbreak surveillance of group A streptococci causing invasive disease in Portugal identified internationally disseminated clones among members of a genetically heterogeneous population. J Clin Microbiol (2007) 1.04
Molecular characterisation of invasive Streptococcus pyogenes isolates from Hungary obtained in 2004 and 2005. Eur J Clin Microbiol Infect Dis (2007) 0.95
emm1/sequence type 28 strains of group A streptococci that express covR at early stationary phase are associated with increased growth and earlier SpeB secretion. J Clin Microbiol (2009) 0.84
Epidemiology of Invasive Group A Streptococcal Disease in Alaska, 2001 to 2013. J Clin Microbiol (2015) 0.80
Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013. PLoS One (2015) 0.79
Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland. J Clin Microbiol (2008) 0.78
The virulence factors of group A streptococcus strains isolated from invasive and non-invasive infections in Polish and German centres, 2009-2011. Eur J Clin Microbiol Infect Dis (2017) 0.75
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med (1996) 8.41
Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A (1991) 5.46
Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect Immun (2001) 5.27
Invasive group A streptococcus infections. Clin Infect Dis (1992) 4.82
Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis (2002) 4.08
Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA (1993) 3.70
emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12
Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis (2005) 3.06
Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun (2000) 2.34
Statement 1996 CA-SFM Zone sizes and MIC breakpoints for non-fastidious organisms. Clin Microbiol Infect (1996) 2.02
Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. J Bacteriol (2004) 1.95
Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002. Clin Infect Dis (2004) 1.95
Group A streptococci in the 1990s. J Antimicrob Chemother (2000) 1.87
M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. J Clin Microbiol (2002) 1.51
Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J Clin Microbiol (2005) 1.50
Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis (2003) 1.48
Molecular subtyping of prevalent M serotypes of Streptococcus pyogenes causing invasive disease. J Clin Microbiol (1995) 1.41
Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clin Infect Dis (1998) 1.36
Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong. J Clin Microbiol (2003) 1.34
Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991. J Clin Microbiol (1992) 1.25
Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol (2003) 1.23
Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin Infect Dis (1998) 1.15
A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J Antimicrob Chemother (2004) 1.07
Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Scand J Infect Dis (2000) 1.04
Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993-1994. J Med Microbiol (2000) 1.03
Invasive group a streptococcal infections, Israel. Emerg Infect Dis (2002) 1.02
Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study. J Clin Microbiol (2005) 0.93
Strep-EURO: progress in analysis and research into severe streptococcal disease in Europe, 2003-2004. Euro Surveill (2005) 0.87
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis (2013) 3.61
New method for typing Staphylococcus aureus strains: multiple-locus variable-number tandem repeat analysis of polymorphism and genetic relationships of clinical isolates. J Clin Microbiol (2003) 2.96
Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol (2009) 2.80
Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland. J Antimicrob Chemother (2002) 2.49
Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob Agents Chemother (2002) 2.29
Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis, spa typing, and multilocus sequence typing for clonal characterization of Staphylococcus aureus isolates. J Clin Microbiol (2005) 2.16
Evaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection. J Clin Microbiol (2007) 1.85
Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species. J Clin Microbiol (2008) 1.81
Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol (2008) 1.81
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland. Antimicrob Agents Chemother (2009) 1.75
Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex. J Clin Microbiol (2007) 1.70
Varicella vaccination in Europe - taking the practical approach. BMC Med (2009) 1.63
Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009. Antimicrob Agents Chemother (2011) 1.58
Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countries. Antimicrob Agents Chemother (2002) 1.56
High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter study. PLoS One (2012) 1.53
Molecular epidemiology of acquired-metallo-beta-lactamase-producing bacteria in Poland. Antimicrob Agents Chemother (2006) 1.42
Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program. J Antimicrob Chemother (2003) 1.37
Two different extended-spectrum beta-lactamases (ESBLs) in one of the first ESBL-producing salmonella isolates in Poland. J Clin Microbiol (2002) 1.34
Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe. J Antimicrob Chemother (2004) 1.34
Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob Agents Chemother (2008) 1.33
First report of Streptococcus pneumoniae serotype 6D isolates from invasive infections. Vaccine (2010) 1.20
International clones of Klebsiella pneumoniae and Escherichia coli with extended-spectrum beta-lactamases in a Czech hospital. J Clin Microbiol (2009) 1.17
An Enterococcus faecium secreted antigen, SagA, exhibits broad-spectrum binding to extracellular matrix proteins and appears essential for E. faecium growth. Infect Immun (2003) 1.16
New selective and differential chromogenic agar medium, chromID VRE, for screening vancomycin-resistant Enterococcus species. J Microbiol Methods (2009) 1.14
Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. Antimicrob Agents Chemother (2002) 1.12
A new rapid and cost-effective method for detection of phages, ICEs and virulence factors encoded by Streptococcus pyogenes. Pol J Microbiol (2011) 1.12
A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J Antimicrob Chemother (2004) 1.07
Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland. Antimicrob Agents Chemother (2004) 1.07
Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004). Int J Antimicrob Agents (2008) 1.06
Distribution of the serine-aspartate repeat protein-encoding sdr genes among nasal-carriage and invasive Staphylococcus aureus strains. J Clin Microbiol (2006) 1.04
Regional spread of Pseudomonas aeruginosa ST357 producing IMP-7 metallo-β-lactamase in Central Europe. J Clin Microbiol (2010) 1.03
Comparison of PCR-based methods for typing Staphylococcus aureus isolates. J Clin Microbiol (2006) 1.03
The relBE2Spn toxin-antitoxin system of Streptococcus pneumoniae: role in antibiotic tolerance and functional conservation in clinical isolates. PLoS One (2010) 1.00
Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication. Pol J Microbiol (2005) 1.00
Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland. Antimicrob Agents Chemother (2007) 1.00
Population structure, virulence factors and resistance determinants of invasive, non-invasive and colonizing Streptococcus agalactiae in Poland. J Antimicrob Chemother (2010) 0.99
Two clones of methicillin-resistant Staphylococcus aureus in Poland. Clin Microbiol Infect (1997) 0.99
Evolution of TEM-type extended-spectrum beta-lactamases in clinical Enterobacteriaceae strains in Poland. Antimicrob Agents Chemother (2005) 0.99
Staphylococcal cassette chromosome mec (Sccmec) classification and typing methods: an overview. Pol J Microbiol (2011) 0.98
Molecular surveillance of methicillin-resistant Staphylococcus aureus by multiple-locus variable number tandem repeat fingerprinting (formerly multiple-locus variable number tandem repeat analysis) and spa typing in a hierarchic approach. Diagn Microbiol Infect Dis (2008) 0.95
Characteristics of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolated from the nasopharynges of asymptomatic children and molecular analysis of S. pneumoniae and H. influenzae strain replacement in the nasopharynx. J Clin Microbiol (2004) 0.95
Expansion and evolution of the Streptococcus pneumoniae Spain9V-ST156 clonal complex in Poland. Antimicrob Agents Chemother (2010) 0.94
Clonal structure of Enterococcus faecalis isolated from Polish hospitals: characterization of epidemic clones. J Clin Microbiol (2006) 0.94
Countrywide molecular survey of methicillin-resistant Staphylococcus aureus strains in Poland. J Clin Microbiol (2008) 0.94
Detection of Streptococcus pyogenes virulence factors by multiplex PCR. Virulence (2012) 0.93
Multilocus variable number tandem repeat analysis (MLVA) of Streptococcus pyogenes. J Microbiol Methods (2011) 0.91
Typing of Streptococcus pyogenes strains using the phage profiling method. Virulence (2012) 0.91
Insight into antimicrobial susceptibility and population structure of contemporary human Enterococcus faecalis isolates from Europe. J Antimicrob Chemother (2011) 0.91
Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20. Antimicrob Agents Chemother (2007) 0.90
Efficiency of the Cepheid Xpert vanA/vanB assay for screening of colonization with vancomycin-resistant enterococci during hospital outbreak. Antonie Van Leeuwenhoek (2011) 0.90
Usefulness of multiple-locus VNTR fingerprinting in detection of clonality of community- and hospital-acquired Staphylococcus aureus isolates. Antonie Van Leeuwenhoek (2008) 0.89
The current status of invasive pneumococcal disease in Poland. Vaccine (2010) 0.89
Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing. Antimicrob Agents Chemother (2010) 0.89
Intercenter reproducibility of binary typing for Staphylococcus aureus. J Microbiol Methods (2002) 0.89
Identification of multidrug-resistant Streptococcus pneumoniae strains isolated in Poland by multilocus sequence typing. Microb Drug Resist (2003) 0.89
Multilocus sequence types, serotypes, and variants of the surface antigen PspA in Streptococcus pneumoniae isolates from meningitis patients in Poland. Clin Vaccine Immunol (2006) 0.87
A decade of invasive meningococcal disease surveillance in Poland. PLoS One (2013) 0.87
Complex endemic situation regarding extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a hospital in Slovenia. Microb Drug Resist (2003) 0.87
Phenotypic and molecular analysis of penicillin-nonsusceptible Streptococcus pneumoniae isolates in Poland. Antimicrob Agents Chemother (2006) 0.86
Molecular epidemiology of Serratia marcescens in two hospitals in Gdańsk, Poland, over a 5-year period. J Clin Microbiol (2004) 0.85
Clonal structure of the methicillin-resistant Staphylococcus aureus (MRSA) population in Poland: revision and update. Microb Drug Resist (2005) 0.84
Characteristics of Haemophilus influenzae type b responsible for meningitis in Poland from 1997 to 2004. J Clin Microbiol (2005) 0.84
Pyogenic streptococci--danger of re-emerging pathogens. Pol J Microbiol (2010) 0.83
Abundance and diversity of plasmid-associated genes among clinical isolates of Enterococcus faecalis. Plasmid (2013) 0.83
[Alexander Project--5 years in Poland]. Pol Merkur Lekarski (2003) 0.83
Characterization of transcription within sdr region of Staphylococcus aureus. Antonie Van Leeuwenhoek (2010) 0.83
Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia. PLoS One (2013) 0.82
Genetic relatedness, antibiotic susceptibility, and serotype distribution of Streptococcus pneumoniae responsible for meningitis in Poland, 1997-2001. Microb Drug Resist (2003) 0.82
Molecular analysis of Acinetobacter baumannii isolates from invasive infections in 2009 in Poland. J Clin Microbiol (2012) 0.81
Nosocomial outbreak of Streptococcus pneumoniae Spain9V‑ST156‑14 clone in a pulmonary diseases ward. Pol Arch Med Wewn (2012) 0.81
The first Staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland. J Antimicrob Chemother (2002) 0.81
Detection of OXA-48-type carbapenemase-producing Enterobacteriaceae in diagnostic laboratories can be enhanced by addition of bicarbonates to cultivation media or reaction buffers. Folia Microbiol (Praha) (2014) 0.81
The new strategy for allele identification of the genes coding for pertussis toxin subunit S1 (ptx S1) and pertactin (prn) in Bordetella pertussis. J Microbiol Methods (2003) 0.81
Drug-resistant and hospital-associated Enterococcus faecium from wastewater, riverine estuary and anthropogenically impacted marine catchment basin. BMC Microbiol (2014) 0.81
Automated peritoneal dialysis-associated peritonitis due to Haemophilus influenzae showing the BLNAR phenotype. Int J Infect Dis (2009) 0.80
High genetic diversity of ciprofloxacin-nonsusceptible isolates of Streptococcus pneumoniae in Poland. Antimicrob Agents Chemother (2005) 0.79
Polymorphism, genetic exchange and intragenic recombination of the aureolysin gene among Staphylococcus aureus strains. BMC Microbiol (2008) 0.79
Prevalence and serotype distribution of encapsulated Haemophilus influenzae isolates from patients with lower respiratory tract infections in Poland. J Clin Microbiol (2005) 0.79
The effect of an antibiotic policy on the control of vancomycin-resistant enterococci outbreak and on the resistance patterns of bacteria isolated from the blood of patients in a hematology unit. Pol Arch Med Wewn (2009) 0.79
[European Antibiotic Awareness Day educational campaign--has it changed public attitudes to antibiotic use in Poland?]. Pol Merkur Lekarski (2010) 0.78
[Invasive pneumococcal disease in Poland in 2010]. Pol Merkur Lekarski (2011) 0.78
Complex nature of enterococcal pheromone-responsive plasmids. Pol J Microbiol (2010) 0.78
[Invasive pneumococcal disease in the Malopolska region of Poland, in the year 2002-2008. Is introduction of mass vaccination with conjugated pneumococcal vaccine justified?]. Med Wieku Rozwoj (2010) 0.77
Invasive meningococcal disease associated with a very high case fatality rate in the North-West of Poland. FEMS Immunol Med Microbiol (2006) 0.77